Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

Lin Ru Koonga National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore

, MBBS,

Wai Kitt Cheea National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore

, MMed,

Zhi Hong Toha National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore

, MBBS,

Xin Le Nga National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore

, MBBS,

Rupesh Agrawala National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore;b Lee Kong Chian School of Medicine, Singapore;c Ocular Infections and AntiMicrobials, Singapore Eye Research Institute, Singapore;d Ophthalmology and Visual Sciences, Academic and Clinical Programme, Duke NUS Medical School, SingaporeCorrespondence[email protected]

https://orcid.org/0000-0002-6662-5850

, FRCSEd

Su Ling Hoa National Healthcare Group Eye Institute, Tan Tock Seng Hospital, SingaporeCorrespondence[email protected]

, FRCSEd

ABSTRACT

A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.

KEYWORDS:

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

Information for

Open access

Opportunities

Help and information

Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

ABSTRACT

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature